Provided by Tiger Trade Technology Pte. Ltd.

Inovio Pharmaceuticals

1.66
+0.10006.41%
Post-market: 1.690.0272+1.64%19:59 EST
Volume:1.24M
Turnover:2.06M
Market Cap:114.05M
PE:-0.61
High:1.73
Open:1.60
Low:1.59
Close:1.56
52wk High:2.98
52wk Low:1.30
Shares:68.70M
Float Shares:66.44M
Volume Ratio:1.00
T/O Rate:1.86%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.7200
EPS(LYR):-3.9488
ROE:-328.45%
ROA:-63.56%
PB:-14.77
PE(LYR):-0.42

Loading ...

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
7 hours ago

Inovio Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Feb 05

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Feb 03

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jan 31

Inovio Pharmaceuticals Inc. Stock Advances 5.2%, Outperforms Peers

Dow Jones
·
Jan 30

Inovio Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Jan 28

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jan 23

Inovio Pharmaceuticals Inc. Stock Sheds 3.7%, Underperforms Peers

Dow Jones
·
Jan 16

Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Jan 13

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jan 08

Inovio Pharmaceuticals Inc. Stock Slides 5.9%, Underperforms Peers

Dow Jones
·
Jan 06

Inovio Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Jan 03

Inovio Pharmaceuticals Inc. Stock Rallies 1.7%, Outperforms Peers

Dow Jones
·
Dec 31, 2025

Inovio Pharmaceuticals Inc. Stock Slides 24.5%, Underperforms Peers

Dow Jones
·
Dec 30, 2025

Inovio Stock Sinks As FDA Pushes Back On Accelerated Approval For Rare Disease Drug

Benzinga_recent_news
·
Dec 30, 2025

Inovio Shares Drop After FDA Says No Plans to Discuss INO-3107 Application

Dow Jones
·
Dec 29, 2025

FDA Accepts Inovio's BLA for INO-3107 to Treat Recurrent Respiratory Papillomatosis

Reuters
·
Dec 29, 2025

Inovio Pharmaceuticals Inc: Not Currently Planning to Seek Approval for Ino-3107 Under Traditional Pathway

THOMSON REUTERS
·
Dec 29, 2025

Inovio Pharmaceuticals Inc - FDA Sets Pdufa Review Date for Ino-3107 on October 30, 2026

THOMSON REUTERS
·
Dec 29, 2025

FDA Accepts for Review Inovio's Bla for Ino-3107 for the Treatment of Adults With Recurrent Respiratory Papillomatosis (Rrp)

THOMSON REUTERS
·
Dec 29, 2025